Table 1.
Baseline characteristics.
| All Patients (n = 139) 100% | MACE (n = 12) 9% | No MACE (n = 127) 91% | p-Value | |
|---|---|---|---|---|
| Age, years | 59.4 (14.7) | 70.0 (8.89) | 58.4 (14.7) | 0.008 |
| Male | 103 (74) | 10 (83) | 93 (73) | 0.4 |
| BMI, kg/m2 | 26.25 (4.79) | 27.0 (5.70) | 26.1 (4.70) | 0.5 |
| Ever smoker | 58 (42) | 4 (33) | 54 (44) | 0.4 |
| Diabetes mellitus | 30 (22) | 6 (50) | 24 (19) | 0.02 |
| Dyslipidemia | 43 (31) | 7 (58) | 36 (29) | 0.051 |
| Hypertension | 48 (35) | 5 (41) | 43 (34) | 0.6 |
| Family history of CAD | 20 (14) | 1 (8) | 19 (15) | 0.5 |
| CMR measurements | ||||
| LVEF (%) | 31.1(11.02) | 24.1 (6.64) | 31.7 (11.1) | 0.02 |
| LVEDVi (mL/m2) | 123.5 (35.4) | 139.1 (23.0) | 120.0 (36.0) | 0.1 |
| LVESVi (mL/m2) | 86.3 (34.6) | 106.0 (22.4) | 84.0 (35.1) | 0.03 |
| LV mass index (g/m2) | 72.4 (20.6) | 78.5 (19.5) | 71.8 (20.7) | 0.2 |
| LA size (mL/m2) | 72.9 (25.5) | 80.8 (24.9) | 72.2 (25.6) | 0.3 |
| Cardiac index (L/mn/m2) | 2.38 (0.72) | 2.73 (0.94) | 2.34 (0.69) | 0.08 |
| RVEF (%) | 41.8 (14.3) | 32.8 (10.3) | 42.9 (14.1) | 0.04 |
| RVEDVi (mL/m2) | 91.8 (32.2) | 94.4 (28.6) | 91.5 (32.9) | 0.8 |
| RVESVi (mL/m2) | 54.2 (29.0) | 65.2 (29.1) | 52.3 (28.9) | 0.2 |
| LGE | ||||
| Presence (%) | 93 (66) | 9 (75) | 84 (66) | 0.5 |
| Extent (% of total LV mass) | 7.4 (10.03) | 9.63 (10.88) | 7.19 (9.9) | 0.4 |
| LGE by Location | ||||
| LGE septal (%) | 57 (41) | 7 (58) | 50 (39) | 0.2 |
| LGE by pattern and distribution | ||||
| -Sub-endocardial (%) | 21 (15) | 3 (25) | 18 (14) | 0.39 |
| -Mid-wall linear (%) | 58 (42) | 4 (33) | 54 (43) | 0.53 |
| -Mid-wall nodular (%) | 2 (1) | 0 (0) | 2 (2) | 0.8 |
| -Multiple patterns (%) | 12 (9) | 2 (16) | 10 (8) | 0.27 |
| Coronary atherosclerotic burden | ||||
| Gensini score | 0 (0–3) | 3.75 (2–15) | 0 (0–3) | 0.0001 |
Values are mean ± standard deviation (SD) or median (interquartile range) or n (%). BMI: body mass index; CAD: coronary artery disease; CMR: cardiovascular magnetic resonance imaging; LA: left atrium; LGE: late gadolinium enhancement; LV: left ventricular; LVEDVi: left ventricular end-diastolic volume index; LVEF: left ventricular ejection fraction; LVESVi: left ventricular end-systolic volume index; RVEF: right ventricular ejection fraction; RVEDVi: right ventricular end-diastolic volume index; RVESVi: right ventricular end-systolic volume index; PCI: percutaneous coronary intervention.